SCA
CLB icon

SAC Capital Advisors’s Core Laboratories CLB Stock Holding History

SAC Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,658
Closed -$1.27M – 1772
2013
Q4 		$1.27M Buy
6,658
+5,151
+342% +$959K 0.01% 837
2013
Q3 		$255K Sell
1,507
-2,601
-63% -$404K ﹤0.01% 1471
2013
Q2 		$623K Buy
+4,108
New +$582K ﹤0.01% 1032

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

SAC Capital Advisors's CLB Position: Q1 2014 in Review

SAC Capital Advisors sold out of Core Laboratories (CLB) in Q1 2014, closing a stake of 6,658 shares — an estimated $1.27M sold.

SAC Capital Advisors first reported a position in CLB in Q2 2013 and held it in 3 quarters. The position peaked at $1.27M in Q4 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q1 2014.

  • SAC Capital Advisors reported no remaining Core Laboratories position as of Q1 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 6,658 Core Laboratories shares in Q1 2014, an estimated $1.27M.
  • SAC Capital Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 3 quarters.
  • SAC Capital Advisors's Core Laboratories position peaked at $1.27M in Q4 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.